Academic Journal

Targeting cellular senescence with Traditional Chinese Medicine: advances in neurodegenerative disorder treatment.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: Targeting cellular senescence with Traditional Chinese Medicine: advances in neurodegenerative disorder treatment.
Συγγραφείς: Hai H; Department of Rheumatology and Immunology, General Hospital of Western Theater Command, Chengdu, Sichuan, China., Li M; Department of Rheumatology and Immunology, General Hospital of Western Theater Command, Chengdu, Sichuan, China., Hu X; Department of Oncology, General Hospital of Western Theater Command, Chengdu, Sichuan, China., Peng J; Department of Oncology, General Hospital of Western Theater Command, Chengdu, Sichuan, China., He Z; Department of Rheumatology and Immunology, General Hospital of Western Theater Command, Chengdu, Sichuan, China.
Πηγή: Frontiers in neurology [Front Neurol] 2026 Aug 19; Vol. 17, pp. 1875385. Date of Electronic Publication: 2026 Aug 19 (Print Publication: 2026).
Τύπος έκδοσης: Journal Article; Review; Systematic Review
Γλώσσα: English
Στοιχεία περιοδικού: Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101546899 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-2295 (Electronic) Linking ISSN: 16642295 NLM ISO Abbreviation: Front Neurol Subsets: MEDLINE
Imprint Name(s): Original Publication: [Lausanne : Frontiers Research Foundation, 2010]-
Ιατρικοί όροι (MeSH): Cellular Senescence*/drug effects , Cellular Senescence*/physiology , Neurodegenerative Diseases*/drug therapy , Neurodegenerative Diseases*/metabolism , Medicine, Chinese Traditional*/methods , Drugs, Chinese Herbal*/therapeutic use , Drugs, Chinese Herbal*/pharmacology, Signal Transduction/drug effects ; Humans ; Animals
Περίληψη: Neurodegenerative diseases (NDDs), including Alzheimer's disease (AD), Parkinson's disease (PD), and Huntington's disease (HD), represent formidable health challenges, particularly within aging populations. Cellular senescence, marked by irreversible cell cycle arrest and the secretion of pro-inflammatory cytokines, has emerged as a crucial factor in the pathogenesis of these disorders. The accumulation of senescent cells in the nervous system exacerbates neuroinflammation, impairs neuronal function, and accelerates tissue degeneration, all of which are key features of NDDs. In this context, bioactive components derived from Traditional Chinese Medicine (TCM) have attracted significant attention for their potential to modulate cellular senescence and alleviate neurodegeneration. This review examines the shared molecular signaling pathways linking cellular senescence to NDDs, explores the mechanisms by which TCM-derived compounds-such as ginsenosides, ginkgo biloba extract, and curcumin-intervene in senescence-related processes, and discusses the translational potential of these natural compounds for clinical application.
(Copyright © 2026 Hai, Li, Hu, Peng and He.)
Competing Interests: The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References: Nutr Neurosci. 2023 Aug;26(8):727-742. (PMID: 35694842)
FASEB J. 2003 Oct;17(13):1954-6. (PMID: 12897068)
Hum Mol Genet. 2009 Aug 15;18(16):3039-47. (PMID: 19465745)
Int J Mol Sci. 2022 Dec 30;24(1):. (PMID: 36614118)
Int J Mol Sci. 2019 May 31;20(11):. (PMID: 31151322)
Reprod Biomed Online. 2020 Sep;41(3):373-384. (PMID: 32651107)
Curr Neurovasc Res. 2023;20(3):314-333. (PMID: 37488757)
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2019 Sep;35(9):806-811. (PMID: 31750822)
Oxid Med Cell Longev. 2022 Aug 17;2022:3086010. (PMID: 36035216)
J Nutr Biochem. 2013 Aug;24(8):1415-22. (PMID: 23849454)
Redox Biol. 2021 Nov;47:102134. (PMID: 34600334)
Int J Pharm. 2017 Jun 30;526(1-2):413-424. (PMID: 28495580)
PLoS One. 2015 Feb 03;10(2):e0115341. (PMID: 25647160)
PLoS One. 2010 Apr 01;5(4):e9979. (PMID: 20376313)
ACS Omega. 2022 Aug 17;7(34):29909-29922. (PMID: 36061679)
Cell. 2012 Apr 13;149(2):274-93. (PMID: 22500797)
Am J Alzheimers Dis Other Demen. 2023 Jan-Dec;38:15333175231205445. (PMID: 37818604)
Physiol Rev. 2018 Jul 1;98(3):1169-1203. (PMID: 29717933)
Cell. 2019 Oct 31;179(4):813-827. (PMID: 31675495)
Ear Nose Throat J. 2021 Jun;100(3_suppl):269S-276S. (PMID: 31554431)
Mol Med Rep. 2014 Apr;9(4):1237-41. (PMID: 24549741)
Br J Ophthalmol. 2024 Jun 20;108(7):989-998. (PMID: 37339867)
Int Rev Neurobiol. 2020;155:203-234. (PMID: 32854855)
Front Pharmacol. 2021 Sep 23;12:735812. (PMID: 34630111)
Chin Med. 2020 Nov 19;15(1):122. (PMID: 33292377)
Int J Mol Sci. 2022 Aug 11;23(16):. (PMID: 36012242)
J Nat Prod. 2020 Mar 27;83(3):770-803. (PMID: 32162523)
J Huntingtons Dis. 2015;4(1):1-15. (PMID: 25813218)
Pharmaceuticals (Basel). 2024 Oct 17;17(10):. (PMID: 39459027)
Oxid Med Cell Longev. 2017;2017:4517486. (PMID: 28690763)
J Mol Med (Berl). 2022 Apr;100(4):537-553. (PMID: 35275221)
Cell Physiol Biochem. 2018;47(2):604-616. (PMID: 29794436)
Int J Mol Sci. 2021 Oct 23;22(21):. (PMID: 34768878)
Biomedicines. 2021 May 19;9(5):. (PMID: 34069618)
Neurobiol Aging. 2021 Apr;100:48-58. (PMID: 33486357)
Mol Biol Rep. 2024 May 25;51(1):694. (PMID: 38796662)
ACS Nano. 2020 Feb 25;14(2):1533-1549. (PMID: 32027482)
PLoS One. 2015 Apr 29;10(4):e0124837. (PMID: 25924011)
Am J Neurodegener Dis. 2016 Mar 01;5(1):52-61. (PMID: 27073742)
Neural Regen Res. 2016 Feb;11(2):319-25. (PMID: 27073387)
Pharmacol Ther. 2004 Oct;104(1):29-45. (PMID: 15500907)
Cell Signal. 2012 Apr;24(4):835-45. (PMID: 22182507)
Brain Behav Immun. 2018 Mar;69:351-363. (PMID: 29253574)
Trends Cell Biol. 2018 Jun;28(6):436-453. (PMID: 29477613)
Nat Cell Biol. 2019 Jan;21(1):63-71. (PMID: 30602761)
Front Aging. 2022 Jul 15;3:926627. (PMID: 35912040)
Neurobiol Aging. 2018 Mar;63:128-139. (PMID: 29304346)
Heliyon. 2024 Jan 18;10(2):e24667. (PMID: 38312669)
Antioxidants (Basel). 2024 May 21;13(6):. (PMID: 38929067)
Mol Cell Neurosci. 2019 Dec;101:103413. (PMID: 31644952)
Aging (Albany NY). 2016 Dec 30;8(12):3535-3551. (PMID: 28077803)
Pharmazie. 2015 Jun;70(6):381-7. (PMID: 26189299)
Int Neurourol J. 2016 May;20(Suppl 1):S2-7. (PMID: 27230456)
Int J Mol Sci. 2023 Sep 19;24(18):. (PMID: 37762556)
Cold Spring Harb Perspect Med. 2016 May 02;6(5):. (PMID: 27048303)
Brain Pathol. 2012 Jan;22(1):99-109. (PMID: 22150925)
Nat Nanotechnol. 2007 Aug;2(8):469-78. (PMID: 18654343)
Aging (Albany NY). 2023 Dec 5;15(23):14473-14505. (PMID: 38054830)
PLoS One. 2012;7(9):e45069. (PMID: 22984612)
Neuroreport. 2019 Sep 4;30(13):867-874. (PMID: 31373965)
Small. 2024 Dec;20(50):e2405781. (PMID: 39370581)
Ageing Res Rev. 2022 Dec;82:101756. (PMID: 36243357)
Drug Metab Rev. 2003 Feb;35(1):35-98. (PMID: 12635815)
Eur J Pharm Sci. 2015 Jun 20;73:35-43. (PMID: 25769523)
Front Aging Neurosci. 2019 Aug 27;11:206. (PMID: 31507403)
EBioMedicine. 2019 Sep;47:446-456. (PMID: 31542391)
Neuropsychiatr Dis Treat. 2015 Oct 13;11:2649-57. (PMID: 26508860)
Front Pharmacol. 2024 Oct 02;15:1434024. (PMID: 39415831)
Int J Dev Neurosci. 2016 Aug;52:66-74. (PMID: 27196502)
Biomolecules. 2023 Sep 25;13(10):. (PMID: 37892126)
Int J Biochem Cell Biol. 2007;39(1):44-84. (PMID: 16978905)
Biomed Res Int. 2021 Mar 29;2021:6688855. (PMID: 33860051)
Sci Rep. 2024 Jul 26;14(1):17665. (PMID: 39085294)
J Intern Med. 2020 Nov;288(5):518-536. (PMID: 32686219)
Front Pharmacol. 2020 Apr 28;11:512. (PMID: 32410992)
Oxid Med Cell Longev. 2022 Apr 12;2022:7511393. (PMID: 35528513)
Curr Drug Res Rev. 2021;13(2):140-147. (PMID: 33290206)
Front Immunol. 2022 Mar 28;13:865772. (PMID: 35418995)
Science. 2011 Nov 4;334(6056):678-83. (PMID: 22053050)
Korean J Physiol Pharmacol. 2020 Jan;24(1):69-79. (PMID: 31908576)
Cells. 2021 Dec 17;10(12):. (PMID: 34944078)
J Diabetes Res. 2023 Feb 10;2023:8776878. (PMID: 36818747)
Int J Mol Med. 2021 Jul;48(1):. (PMID: 33955518)
Int J Mol Sci. 2023 Dec 21;25(1):. (PMID: 38203294)
J Neurosci. 2022 Jul 6;42(27):5294-5313. (PMID: 35672148)
Cell Tissue Res. 2017 Sep;369(3):455-465. (PMID: 28656471)
EBioMedicine. 2019 Feb;40:554-563. (PMID: 30616998)
Transl Neurosci. 2022 Sep 12;13(1):301-308. (PMID: 36160039)
Cell Death Discov. 2018 May 10;4:57. (PMID: 29760955)
Lancet Neurol. 2011 Nov;10(11):1015-25. (PMID: 22014436)
AIMS Neurosci. 2023 Jun 29;10(2):178-189. (PMID: 37426781)
Clin Exp Otorhinolaryngol. 2019 May;12(2):169-175. (PMID: 30360042)
Lancet. 2021 Apr 24;397(10284):1577-1590. (PMID: 33667416)
Nature. 2014 May 22;509(7501):439-46. (PMID: 24848057)
Aging Cell. 2015 Aug;14(4):644-58. (PMID: 25754370)
Int J Mol Sci. 2020 Mar 18;21(6):. (PMID: 32197410)
Int J Mol Sci. 2019 Mar 12;20(5):. (PMID: 30871021)
Sci Rep. 2021 Dec 1;11(1):23237. (PMID: 34853352)
Redox Biol. 2023 Jul;63:102734. (PMID: 37159984)
Exp Ther Med. 2023 May 31;26(1):354. (PMID: 37324509)
Reprod Fertil Dev. 2020 Feb;32(3):292-303. (PMID: 31656219)
Lancet Neurol. 2015 Apr;14(4):388-405. (PMID: 25792098)
Biogerontology. 2017 Aug;18(4):447-476. (PMID: 28258519)
Pharmaceutics. 2023 Feb 23;15(3):. (PMID: 36986610)
Mol Pharm. 2007 Nov-Dec;4(6):807-18. (PMID: 17999464)
Aging Cell. 2018 Dec;17(6):e12840. (PMID: 30126037)
Iran J Basic Med Sci. 2024;27(3):360-365. (PMID: 38333746)
Nat Med. 2018 Aug;24(8):1246-1256. (PMID: 29988130)
Eur J Pharmacol. 2024 Nov 15;983:177004. (PMID: 39278310)
Molecules. 2020 May 29;25(11):. (PMID: 32486047)
Sci Rep. 2016 Nov 18;6:36698. (PMID: 27857162)
Adv Sci (Weinh). 2024 Jun;11(24):e2306675. (PMID: 38647399)
Nat Rev Mol Cell Biol. 2013 Apr;14(4):197-210. (PMID: 23847781)
Med Sci Monit. 2019 Oct 12;25:7666-7674. (PMID: 31605603)
Nucleic Acids Res. 2024 May 22;52(9):5107-5120. (PMID: 38554113)
Transl Cancer Res. 2024 Jul 31;13(7):3251-3261. (PMID: 39145095)
Brain. 2017 May 1;140(5):1399-1419. (PMID: 28398476)
Pharmacol Ther. 2022 Sep;237:108171. (PMID: 35304223)
J Clin Invest. 2017 Dec 1;127(12):4379-4393. (PMID: 29106387)
Mol Cell. 2012 Oct 26;48(2):158-67. (PMID: 23102266)
Nature. 2013 Jan 17;493(7432):338-45. (PMID: 23325216)
ACS Nano. 2024 Jan 30;18(4):3234-3250. (PMID: 38214975)
Pharmaceuticals (Basel). 2022 Aug 25;15(9):. (PMID: 36145272)
Int J Mol Sci. 2019 Mar 12;20(5):. (PMID: 30871042)
Sci Rep. 2020 Mar 4;10(1):4023. (PMID: 32132570)
J Pathol. 2010 May;221(1):3-12. (PMID: 20225336)
Nat Genet. 2004 Jun;36(6):585-95. (PMID: 15146184)
Curr Protein Pept Sci. 2011 Feb;12(1):30-42. (PMID: 21190521)
Aging Dis. 2018 Aug 1;9(4):590-604. (PMID: 30090649)
Adv Sci (Weinh). 2025 Jan;12(2):e2407222. (PMID: 39558862)
Neuroscience. 2010 Sep 1;169(3):1296-306. (PMID: 20538041)
Neural Regen Res. 2014 May 1;9(9):943-50. (PMID: 25206916)
Neurochem Res. 2023 Nov;48(11):3378-3390. (PMID: 37436612)
Am J Transl Res. 2021 Mar 15;13(3):1471-1482. (PMID: 33841671)
Neurobiol Dis. 2020 Oct;144:105028. (PMID: 32736085)
JAMA. 2008 Nov 19;300(19):2253-62. (PMID: 19017911)
Mov Disord. 2013 Jun;28(6):725-32. (PMID: 23580333)
J Biol Chem. 2003 Jun 13;278(24):21592-600. (PMID: 12682069)
Autophagy. 2005 Apr;1(1):11-22. (PMID: 16874045)
Medicine (Baltimore). 2022 Nov 18;101(46):e31944. (PMID: 36401446)
PLoS One. 2014 Oct 15;9(10):e110275. (PMID: 25333784)
J Neurochem. 2006 Apr;97(1):105-15. (PMID: 16524383)
Molecules. 2017 Sep 10;22(9):. (PMID: 28891967)
Nature. 2018 Oct;562(7728):578-582. (PMID: 30232451)
Exp Ther Med. 2021 Sep;22(3):951. (PMID: 34335893)
Drug Metab Dispos. 2004 Dec;32(12):1377-82. (PMID: 15333514)
CNS Neurosci Ther. 2024 Jun;30(6):e14692. (PMID: 38872258)
Cell Cycle. 2009 Jun 15;8(12):1888-95. (PMID: 19471117)
Nutr Rev. 2012 May;70(5):257-65. (PMID: 22537212)
J Ginseng Res. 2023 Mar;47(2):337-346. (PMID: 36926607)
Nat Rev Neurol. 2019 Oct;15(10):565-581. (PMID: 31501588)
Trends Neurosci. 2024 Jun;47(6):461-474. (PMID: 38729785)
J Neurochem. 2021 Sep;158(6):1381-1393. (PMID: 33930191)
Int J Mol Sci. 2021 Apr 17;22(8):. (PMID: 33920726)
Nat Neurosci. 2019 May;22(5):719-728. (PMID: 30936558)
Int J Mol Sci. 2023 Mar 28;24(7):. (PMID: 37047299)
Nature. 2019 Jul;571(7764):183-192. (PMID: 31292558)
Aging Cell. 2021 Feb;20(2):e13296. (PMID: 33470505)
EMBO Rep. 2014 Nov;15(11):1139-53. (PMID: 25312810)
Food Funct. 2023 Jul 31;14(15):7209-7221. (PMID: 37463025)
Cell Rep. 2018 Jan 23;22(4):930-940. (PMID: 29386135)
J Biol Chem. 2015 Jan 16;290(3):1885-97. (PMID: 25416785)
Brain Circ. 2019 Apr-Jun;5(2):74-83. (PMID: 31334360)
Cell Mol Neurobiol. 2008 Feb;28(2):173-83. (PMID: 17657601)
Inflammopharmacology. 2023 Jun;31(3):1449-1464. (PMID: 36856916)
Nat Commun. 2018 Dec 21;9(1):5435. (PMID: 30575733)
Front Nutr. 2024 Jul 02;11:1426780. (PMID: 39021599)
Curr Med Sci. 2022 Jun;42(3):474-482. (PMID: 35678907)
Antioxidants (Basel). 2022 Nov 30;11(12):. (PMID: 36552584)
J Ginseng Res. 2023 Sep;47(5):605-614. (PMID: 37720567)
Evid Based Complement Alternat Med. 2022 Sep 12;2022:1767421. (PMID: 36133785)
Mol Neurodegener. 2020 Jan 13;15(1):5. (PMID: 31931835)
Nat Neurosci. 2014 Apr;17(4):513-21. (PMID: 24584051)
Front Cell Dev Biol. 2023 Sep 12;11:1252942. (PMID: 37766966)
Ther Adv Respir Dis. 2023 Jan-Dec;17:17534666231170800. (PMID: 37154390)
Front Pharmacol. 2022 Nov 24;13:921794. (PMID: 36506569)
Cell Mol Life Sci. 2016 Sep;73(17):3221-47. (PMID: 27100828)
Redox Biol. 2017 Oct;13:69-81. (PMID: 28575743)
Molecules. 2019 May 18;24(10):. (PMID: 31109069)
EMBO J. 2015 Feb 3;34(3):275-93. (PMID: 25425574)
PLoS Biol. 2017 Mar 3;15(3):e2000374. (PMID: 28257421)
Brain. 2015 Jun;138(Pt 6):1738-55. (PMID: 25833819)
Mol Neurobiol. 2024 Jul;61(7):4402-4420. (PMID: 38087172)
Mol Immunol. 2019 Dec;116:29-37. (PMID: 31590042)
Nature. 2016 Feb 11;530(7589):184-9. (PMID: 26840489)
Cell Rep. 2014 Sep 25;8(6):1767-1780. (PMID: 25199830)
Oxid Med Cell Longev. 2018 Sep 13;2018:7904349. (PMID: 30302174)
J Proteome Res. 2014 Dec 5;13(12):5734-42. (PMID: 25311616)
Dement Geriatr Cogn Disord. 2006;22(4):320-6. (PMID: 16954686)
Biochemistry. 2006 May 16;45(19):6085-94. (PMID: 16681381)
Nat Rev Drug Discov. 2021 Mar;20(3):200-216. (PMID: 33510482)
Molecules. 2021 Jan 30;26(3):. (PMID: 33573300)
Antioxidants (Basel). 2020 Mar 26;9(4):. (PMID: 32224984)
Front Med (Lausanne). 2024 Jan 05;10:1335512. (PMID: 38249960)
Naunyn Schmiedebergs Arch Pharmacol. 2024 Jul;397(7):4809-4822. (PMID: 38153514)
Int J Mol Sci. 2019 Mar 12;20(5):. (PMID: 30871086)
Contributed Indexing: Keywords: Traditional Chinese Medicine; active components; cellular senescence; neurodegenerative diseases; signaling pathways; therapeutic potential
Substance Nomenclature: 0 (Drugs, Chinese Herbal)
Entry Date(s): Date Created: 20260903 Date Completed: 20260903 Latest Revision: 20260904
Update Code: 20260904
PubMed Central ID: PMC13533672
DOI: 10.3389/fneur.2026.1875385
PMID: 42687999
Βάση Δεδομένων: MEDLINE
Περιγραφή
ISSN:1664-2295
DOI:10.3389/fneur.2026.1875385